504 POSTER GA101, a therapeutic glycoengineered CD20...

504 POSTER GA101, a therapeutic glycoengineered CD20 antibody recognizing a type II epitope mediates outstanding anti-tumor efficacy in Non-Hodgkin lymphoma xenograft models and superior B cell depletion

C. Klein, F. Herting, T. Friess, C. Gerdes, A. Nopora, S. Bauer, R. Grau, E. Moessner, J. Dal Porto, P. Umana
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)72438-8
File:
PDF, 59 KB
english, 2008
Conversion to is in progress
Conversion to is failed